Global Depression Drugs Market: Growing Geriatric Population Noticed by Variant Market Research

According to the latest report published by Variant Market Research, the global depression drugs market size is projected to reach$18 billion by 2025 from $15 billion in 2017. In this report, depression drugs market forecast says that the global market is growing at 2.6% CAGR from 2017 to 2025.

Click Here to Request a Free Sample PDF of This Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/depression-drugs-market/sample-request

Decreasing side effects of depression drugs to drive the global depression drugs market

The global depression drugs market trend includes growing geriatric population, increasing efficacy, decreasing side effects of depression drugs, and increase in the number of generic drug market. Moreover, depression drug companies in the market are offering variety of anti depression drug, which benefits the individual during the depression drug treatment. Though, absence of responsiveness among people about depression & its increasing occurrence may obstruct the market growth. Moreover, increasing incidences of restlessness and several other depression disorders would provide an opportunity for market players of market.

Market Segmentations

The global depression drugs market is classified into product type, application, and geography. Product types of depression drugs includes anticonvulsants, serotonin-norepinephrine reuptake inhibitors (SNRIs), benzodiazepines, beta-blockers, selective serotonin reuptake inhibitors (SSRIs), tetracyclic antidepressants (TeCAs), and monoamine oxidase inhibitors (MAOIs). Further, the market is classified on basis of application into clinics and hospitals, and research centers. North America (U.S., Mexico, and Canada), Europe (France, Germany, Spain, UK, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific) and RoW (Middle East, South America, and Africa) are the key geographical regions included in this market.

Get Table of Content (TOC) @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/depression-drugs-market/toc

SNRIs, by product type, is estimated to dominated the global market in 2017

SNRIs held for the highest market share in 2017, and expected to continue its dominance over the forecast period, 2017– 2025, due to the increase in demand of serotonin-norepinephrine reuptake inhibitors (SNRIs).

North America is estimated to dominated the global market in 2017

North America held for the highest market share in 2017, and expected to continue its dominance over the forecast period, 2017– 2025, due to the huge consumer base suffering by many kinds of depression & anxiety disorders. Additionally, Asia-Pacific (including countries like Australia, Singapore, and Philippines, among others) is expected to grow at a fastest CAGR during the forecasted period.

To browse the complete report, visit at https://www.variantmarketresearch.com/report-categories/pharmaceuticals/depression-drugs-market

Competitive Landscape

Major depression drug manufacturers are Merck & Co., H. Lundbeck, SK Biopharmaceuticals, Novartis, Forest Laboratories, AstraZeneca, Naurex, GlaxoSmithKline, Naurex, and Eli Lilly and Co., among others.

Scope of Depression Drugs Market

 Product Type Segments

• Tricyclice Antidepressants
• Serotonin-Norepinephrine Inhibitors
• Atypical Antipsychotics
• Selective Serotonin Reuptake Inhibitors
• Benzodiazepines, Tetracyclic Antidepressants
• Monoamine Oxidase Inhibitors
• Others

Application Segments

• Clinics and Hospitals
• Research centres

Geographical Segments

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Others
• RoW
• South America
• Middle East
• Africa

About Variant Market Research

Variant Market Research offers syndicated and customized reports to fulfill clients' objectives. We also provide customized data pack proposing market sizing in an Excel/PDF/PowerPoint or Word format as per the requirement of clients. We cover several industry domains, namely Semiconductor & Electronics, Consumer Electronics, Information and Communication Technology, Automotive, Consumer Goods, Food & Beverages, Pharmaceuticals, Medical Devices, Chemicals, Industrial, Mining Equipment, Automation, Manufacturing, Construction, Energy & Power, Defense & Aerospace and Banking, Financial services and Insurance (BFSI). Our expertise are data triangulation, competitor benchmarking, parent market benchmarking, estimating market size and forecast of the market from 2016 to 2024.

Contact Us

John Dave,
Head - Sales
Variant Market Research
649 Mission St, 5th Floor, San Francisco, CA 94105, United States.
Tel: +1-415-680-2785
Fax: +1-415-680-2786
Email: john.dave@variantmarketresearch.com
Email: help@variantmarketresearch.com